Ooi SL, Micalos PS, Pak SC (2023) Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis. PLoS ONE 18(8): e0290314. https://doi.org/10.1371/journal.pone.0290314
Ooi SL, Micalos PS, Pak SC (2023) Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis. PLoS ONE 18(8): e0290314. https://doi.org/10.1371/journal.pone.0290314
Ooi SL, Micalos PS, Pak SC (2023) Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis. PLoS ONE 18(8): e0290314. https://doi.org/10.1371/journal.pone.0290314
Ooi SL, Micalos PS, Pak SC (2023) Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis. PLoS ONE 18(8): e0290314. https://doi.org/10.1371/journal.pone.0290314
Abstract
Rice bran arabinoxylan compound (RBAC) is a polysaccharide modified by Lentinus edodes mycelial enzyme widely used as a nutraceutical. To explore translational research on RBAC, a scoping review was conducted to synthesise research evidence from English, Japanese, Korean, and Chinese sources while combining bibliometrics and network analyses for data visualisation. Ninety-eight articles on RBAC and the biological activities related to human health or disease were included. Research progressed with linear growth (median=3/year) from 1998 to 2022, predominantly on Biobran MGN-3 (86.73%) and contributed by 289 authors from 100 institutions across 18 countries. Clinical studies constitute 61.1% of recent articles (2018 to 2022). A shifting focus from immuno-cellular activities to human translations over the years was shown via keyword visualisation. Beneficial effects of RBAC include immunomodulation, synergistic anticancer properties, hepatoprotection, antiinflammation, and antioxidation. Cancer patients reported reduced side effects from chemoradiotherapy and improved quality of life in human studies, indicating RBAC’s impact on the psycho-neuro-immune axis. RBAC has been studied in 17 conditions, including cancer, liver diseases, HIV, allergy, chronic fatigue, gastroenteritis, cold/flu, diabetes, and in healthy participants. Further translational research on the impact on patient and community health is required for the evidence-informed use of RBAC in health and disease.
Medicine and Pharmacology, Complementary and Alternative Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
